PNC Financial Services Group
CAPR icon

PNC Financial Services Group’s Capricor Therapeutics CAPR Stock Holding History

PNC Financial Services Group’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506 Sell
21
-3
-13% -$91 ﹤0.01% 4984
2026
Q1 		$730 Buy
24
+3
+14% +$80 ﹤0.01% 4825
2025
Q4 		$606 Sell
21
-217
-91% -$2.83K ﹤0.01% 4799
2025
Q3 		$1.72K Buy
+238
New +$1.75K ﹤0.01% 4544

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PNC Financial Services Group's CAPR Position: Q2 2026 in Review

PNC Financial Services Group reduced its Capricor Therapeutics (CAPR) stake by 13% in Q2 2026, selling an estimated $91 and leaving 21 shares worth $506. The position accounts for ﹤0.01% of the portfolio, ranked #4984.

PNC Financial Services Group first reported a position in CAPR in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.72K in Q3 2025. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • PNC Financial Services Group held 21 shares of Capricor Therapeutics worth $506 as of Q2 2026.
  • PNC Financial Services Group sold 3 Capricor Therapeutics shares in Q2 2026, an estimated $91.
  • Capricor Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4984 holding.
  • PNC Financial Services Group first reported a position in Capricor Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • PNC Financial Services Group's Capricor Therapeutics position peaked at $1.72K in Q3 2025.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.